Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella Catheters

Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre... Cardiol Ther (2015) 4:47–58 DOI 10.1007/s40119-014-0033-8 ORIGINAL RESEARCH Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella Catheters • • • Vinod Venugopal Jon Spiro Alex Zaphiriou • • Sohail Khan Jonathan N. Townend Peter F. Ludman Sagar N. Doshi To view enhanced content go to www.cardiologytherapy-open.com Received: October 19, 2014 / Published online: December 17, 2014 The Author(s) 2014. This article is published with open access at Springerlink.com and 3 patients had Impella as a bridge to cardiac ABSTRACT transplantation. The 2.5L and 3.8L devices were Aims: The Impella is a percutaneous used in 36 (75%) and 11 (23%) patients, ventricular assist device. The majority of respectively, while one patient (2%) had the published data describes the 2.5L and 5.0L 5L device. Vascular complications occurred in devices, and little data is available for the only one patient (2%) and stroke and peri- newer 3.8L device. We examined the procedural myocardial infarction occurred in indications and outcomes from our one patient (2%), while in-hospital mortality single-centre ‘‘real-world’’ registry at The was 20% (10/49). Queen Elizabeth Hospital, Birmingham, UK, Conclusions: In this large real-world registry, using all three pump sizes. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiology and Therapy Springer Journals

Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella Catheters

Download PDF
12 pages

Loading next page...
 
/lp/springer-journals/percutaneous-mechanical-ventricular-support-in-acute-cardiac-care-a-uk-1yjC42afJL
Publisher
Springer Journals
Copyright
Copyright © 2014 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Cardiology
ISSN
2193-8261
eISSN
2193-6544
DOI
10.1007/s40119-014-0033-8
pmid
25515965
Publisher site
See Article on Publisher Site

Abstract

Cardiol Ther (2015) 4:47–58 DOI 10.1007/s40119-014-0033-8 ORIGINAL RESEARCH Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella Catheters • • • Vinod Venugopal Jon Spiro Alex Zaphiriou • • Sohail Khan Jonathan N. Townend Peter F. Ludman Sagar N. Doshi To view enhanced content go to www.cardiologytherapy-open.com Received: October 19, 2014 / Published online: December 17, 2014 The Author(s) 2014. This article is published with open access at Springerlink.com and 3 patients had Impella as a bridge to cardiac ABSTRACT transplantation. The 2.5L and 3.8L devices were Aims: The Impella is a percutaneous used in 36 (75%) and 11 (23%) patients, ventricular assist device. The majority of respectively, while one patient (2%) had the published data describes the 2.5L and 5.0L 5L device. Vascular complications occurred in devices, and little data is available for the only one patient (2%) and stroke and peri- newer 3.8L device. We examined the procedural myocardial infarction occurred in indications and outcomes from our one patient (2%), while in-hospital mortality single-centre ‘‘real-world’’ registry at The was 20% (10/49). Queen Elizabeth Hospital, Birmingham, UK, Conclusions: In this large real-world registry, using all three pump sizes.

Journal

Cardiology and Therapy – Springer Journals

Published: Dec 17, 2014

References

  • Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry
    Maini, B; Naidu, SS; Mulukutla, S
  • Percutaneous mechanical cardiac assist in myocardial infarction. Where are we now, where are we going?
    Sjauw, KD; Engstrom, AE; Henriques, JP
  • Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions ≤40%, 41–49%, and ≥50% having percutaneous coronary revascularization
    Keelan, PC; Johnston, JM; Koru-Sengul, T
  • Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention
    Wallace, TW; Berger, JS; Wang, A; Velazquez, EJ; Brown, DL
  • Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial
    Perera, D; Stables, R; Thomas, M
  • Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
    Thiele, H; Zeymer, U; Neumann, FJ
  • Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock
    Thiele, H; Sick, P; Boudriot, E
  • Combined Impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study
    Sauren, LD; Accord, RE; Hamzeh, K
  • Miniature intracardiac assist device provides more effective cardiac unloading and circulatory support during severe left heart failure than intraaortic balloon pumping
    Reesink, KD; Dekker, AL; Ommen, V
  • Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: case description and review of the literature
    Cubeddu, RJ; Lago, R; Horvath, SA; Vignola, PA; O’Neill, W; Palacios, IF
  • Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics
    Remmelink, M; Sjauw, KD; Henriques, JP
  • Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients
    Remmelink, M; Sjauw, KD; Henriques, JP
  • Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention
    Valgimigli, M; Steendijk, P; Sianos, G; Onderwater, E; Serruys, PW
  • Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry
    Sjauw, KD; Konorza, T; Erbel, R
  • A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study
    O’Neill, WW; Kleiman, NS; Moses, J
  • Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials
    Cheng, JM; Uil, CA; Hoeks, SE
  • A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction
    Seyfarth, M; Sibbing, D; Bauer, I
  • Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry
    Lauten, A; Engstrom, AE; Jung, C
  • Temporary ventricular assist devices in the intensive care unit as a bridge to decision
    Myers, TJ
  • Use of Impella 5L for acute allograft rejection postcardiac transplant
    Chandola, R; Cusimano, R; Osten, M; Horlick, E
  • A novel percutaneous mechanical biventricular bridge to recovery in severe cardiac allograft rejection
    Rajagopal, V; Steahr, G; Wilmer, CI; Raval, NY
  • Acute ventricular septal defect treated with an Impella recovery as a ‘bridge therapy’ to heart transplantation
    Patanè, F; Zingarelli, E; Sansone, F; Rinaldi, M
  • Use of the Impella 5.0 as a bridge from ECMO to implantation of the HeartMate II left ventricular assist device in a pediatric patient
    Hollander, SA; Reinhartz, O; Chin, C
  • Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention
    Perera, D; Stables, R; Clayton, T
  • The right axillary artery approach for the Impella Recover LP 5.0 microaxial pump
    Sassard, T; Scalabre, A; Bonnefoy, E; Sanchez, I; Farhat, F; Jegaden, O
  • Frequency and long-term impact of myonecrosis after coronary stenting
    Brener, SJ; Ellis, SG; Schneider, J; Topol, EJ
  • Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention
    Kini, A; Marmur, JD; Kini, S
  • ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    Steg, PG; James, SK; Atar, D
  • External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention
    Kunadian, B; Dunning, J; Das, R
  • A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial US experience
    Dixon, SR; Henriques, JP; Mauri, L
  • Impella 2.5 assisted balloon aortic valvuloplasty and percutaneous coronary intervention as a bridge to heart transplantation
    Badawi, RA; Grise, MA; Thornton, SN
  • Hemodynamic support with impella 2.5 during balloon aortic valvuloplasty in a high-risk patient
    Londoño, JC; Martinez, CA; Singh, V; O’Neill, WW
  • Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction
    Martinez, CA; Singh, V; Londoño, JC
  • Preliminary experience with Impella Recover((R)) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit
    Bresson, D; Sibellas, F; Farhat, F; Jegaden, O; Kirkorian, G; Bonnefoy, E
  • The cost-effectiveness of a new percutaneous ventricular assist device for high-risk PCI patients: mid-stage evaluation from the European perspective
    Roos, JB; Doshi, SN; Konorza, T
  • 2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Windecker, S; Kolh, P; Alfonso, F